Brief: ADC Therapeutics Provides Business Updates
Jan 4 (Reuters) - ADC Therapeutics SA ADCT.N :
* ADC THERAPEUTICS PROVIDES BUSINESS UPDATES
* ADC THERAPEUTICS SA - MULTIPLE DATA CATALYSTS EXPECTED IN
2024
AND WITH A CASH RUNWAY NOW EXPECTED INTO 4Q 2025
* ADC THERAPEUTICS SA SEES DECREASE IN TOTAL OPERATING
EXPENSES
EXPECTED IN FULL YEAR 2023 AND 2024 AS COMPARED TO 2022
Source text for Eikon: ID:nGNX15twWz
Further company coverage: ADCT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adc Therapeutics
See all newsBrief: Adc Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
ADC Therapeutics SA reports results for the quarter ended June 30 - Earnings Summary
ADC Therapeutics Q2 loss narrows; cuts 17% workforce
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview